生物基因计划在2028年前将总部迁至麻省理工学院在剑桥的肯德尔广场。 Biogen plans to relocate its headquarters to MIT's Kendall Square in Cambridge by 2028.

生物基因是主要的药物制造者,计划在2028年前将其总部迁至麻省理工学院设在马萨诸塞州剑桥的肯德尔广场。 Biogen, a major drugmaker, plans to move its headquarters to MIT's Kendall Square in Cambridge, Massachusetts, by 2028. 此举将该公司的当地业务合并为一栋单一的建筑,标志着Biogen在更新其在马萨诸塞州房地产足迹方面迈出的第一步。 The move consolidates the company’s local operations into a single building and marks Biogen's first step in renewing its real estate footprint in Massachusetts. 新总部将成为与外部伙伴和地方教育机构合作的创新中心。 The new headquarters will serve as an innovation hub for collaborations with outside partners and local educational institutions.